Alnylam launches AMVUTTRA ‘Play by Play’ educational initiative on ATTR-CM

Alnylam Pharmaceuticals said it launched a U.S. educational initiative called ‘Play by Play’ for AMVUTTRA, featuring former athletes and care teams discussing ATTR-CM symptoms and diagnosis. The company said the campaign starts on World Heart Day and aims to encourage earlier recognition of the disease.